Copyright
©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 628-632
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.628
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.628
Table 3 Survival rates according to barcelona clinic liver cancer classification and subclassification
| n (%) | Mean survival rate (mo) (95%CI) | |
| Overall | 136 (100) | 35.8 (25.0-52.0) |
| BCLC A | 46 (33.7) | 38.1 ( 25.0-52.0) |
| BCLC B | 90 (66.2) | 29.0 ( 17.2-34.3) |
| BCLC B1 | 48 (52.8) | 33.6 ( 32.9-34.3) |
| BCLC B2 | 27 (30.2) | 28.6 (27.5-29.8) |
| BCLC B3 | 13 (15.1) | 19.0 ( 17.2-20.9) |
| BCLC B4 | 2 (1.9) | 13.0 ( 25.0-52.0) |
- Citation: Scaffaro LA, Stella SF, Alvares-Da-Silva MR, Kruel CDP. Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma. World J Hepatol 2015; 7(3): 628-632
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/628.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.628